SEC
SlamSEC
SearchBrowseEarnings

Point of Care Nano-Technology, Inc.

Biological Products, (No Diagnostic Substances)·WHITEHOUSE STATION, NJ
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

Revenue
—
Adj. EBITDA
-$71,981
FY 2023
Net Income
-$42,255
FY 2023
EPS (Diluted)
-$0.03
FY 2012
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$3,198
FY 2023
Total Debt
$26,034
FY 2015
Net Debt
$22,836
FY 2015
Enterprise Value
—
Debt / EBITDA
-0.3x
FY 2023
EV / EBITDA
—
Employees
—